This Drug Maker Saw the Pandemic Coming
Prognosis: Losing it
English - May 14, 2020 20:49 - 13 minutes - 12.5 MB - ★★★★ - 372 ratingsScience Health & Fitness Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The Scary Implications of 'Covid Toe'
Next Episode: Can The Aviation Industry Afford To Keep You Safe?
When Covid-19 hit, Gilead Sciences Inc. had enough of its experimental drug remdesivir ready to test and start manufacturing it at a larger scale. That's because it had started stockpiling not just the drug, but its ingredients, at the first hint there may be a new coronavirus. Robert Langreth reports on why the company was able to act early to prepare for a pandemic when so many businesses and institutions did not.
See omnystudio.com/listener for privacy information.